PB28

ICD-11 MMS 2026-01

Unintentional exposure to or harmful effects of other or unspecified drug, medicament or biological substance

Index terms

  • Unintentional exposure to or harmful effects of other or unspecified drug, medicament or biological substance
  • accidental drug overdose
  • accidental overdose
Show allHide
  • accidental overdose of other or unspecified drug, medicament or biological substance
  • accidental poisoning by other or unspecified drug, medicament or biological substance
  • other or unspecified drug, medicament or biological substance taken in error
  • Unintentional exposure to or harmful effects of systemic antibiotics
  • Unintentional exposure to or harmful effects of penicillins
  • Unintentional exposure to or harmful effects of cephalosporins or other beta-lactam antibiotics
  • Unintentional exposure to or harmful effects of chloramphenicol group
  • Unintentional exposure to or harmful effects of macrolides
  • Unintentional exposure to or harmful effects of tetracyclines
  • Unintentional exposure to or harmful effects of aminoglycosides
  • Unintentional exposure to or harmful effects of rifampicin
  • Unintentional exposure to or harmful effects of antifungal antibiotics, systemically used
  • Unintentional exposure to or harmful effects of other systemic anti-infectives or antiparasitics
  • Unintentional exposure to or harmful effects of sulfonamides
  • Unintentional exposure to or harmful effects of antimycobacterial drugs
  • Unintentional exposure to or harmful effects of antimalarials or drugs acting on other blood protozoa
  • Unintentional exposure to or harmful effects of other antiprotozoal drugs
  • Unintentional exposure to or harmful effects of anthelminthics
  • Unintentional exposure to or harmful effects of antiviral drugs
  • Unintentional exposure to or harmful effects of hormones or their synthetic substitutes or antagonists, not elsewhere classified
  • Unintentional exposure to or harmful effects of glucocorticoids or synthetic analogues
  • Unintentional exposure to or harmful effects of thyroid hormones or substitutes
  • Unintentional exposure to or harmful effects of antithyroid drugs
  • Unintentional exposure to or harmful effects of insulin or oral hypoglycaemic drugs
  • Unintentional harmful effect of antidiabetic drugs
  • Unintentional exposure to or harmful effects of oral contraceptives
  • Unintentional exposure to or harmful effects of other estrogens or progestogens
  • Unintentional exposure to or harmful effects of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified
  • Unintentional exposure to or harmful effects of androgens or anabolic congeners
  • Unintentional exposure to or harmful effects of unspecified hormones or synthetic substitutes
  • Unintentional exposure to or harmful effects of anterior pituitary hormones
  • Unintentional harmful effect of adenohypophyseal hormones
  • Unintentional exposure to or harmful effects of other hormones or synthetic substitutes
  • Unintentional exposure to or harmful effects of other hormone antagonists
  • Unintentional exposure to or harmful effects of unspecified hormone antagonists
  • Unintentional exposure to or harmful effects of drugs primarily affecting the autonomic nervous system
  • Unintentional exposure to or harmful effects of anticholinesterase agents
  • Unintentional exposure to or harmful effects of other parasympathomimetics
  • Unintentional harmful effect of cholinergics
  • Unintentional exposure to or harmful effects of ganglionic blocking drugs
  • Unintentional exposure to or harmful effects of other parasympatholytics or spasmolytics
  • Unintentional harmful effect of anticholinergics or antimuscarinics
  • Unintentional exposure to or harmful effects of predominantly alpha-adrenoreceptor agonists
  • Unintentional exposure to or harmful effects of predominantly beta-adrenoreceptor agonists
  • Unintentional exposure to or harmful effects of alpha-adrenoreceptor antagonists
  • Unintentional exposure to or harmful effects of beta-adrenoreceptor antagonists
  • Unintentional exposure to or harmful effects of centrally-acting or adrenergic-neuron-blocking agents
  • Unintentional exposure to or harmful effects of agents primarily affecting blood constituents
  • Unintentional exposure to or harmful effects of diphenhydramine
  • Unintentional exposure to or harmful effects of other H1-receptor antagonists
  • Unintentional exposure to or harmful effects of antiallergic or antiemetic drugs
  • Unintentional exposure to or harmful effects of antineoplastic antimetabolites
  • Unintentional exposure to or harmful effects of antineoplastic natural products
  • Unintentional exposure to or harmful effects of other antineoplastic drugs
  • Unintentional exposure to or harmful effects of immunosuppressive agents
  • Unintentional exposure to or harmful effects of vitamin B12, folic acid or other anti-megaloblastic-anaemia preparations
  • Unintentional exposure to or harmful effects of enzymes
  • Unintentional exposure to or harmful effects of iron or its compounds
  • Unintentional exposure to or harmful effects of anticoagulants
  • Unintentional exposure to or harmful effects of antithrombotic drugs
  • Unintentional harmful effect of platelet aggregation inhibitors
  • Unintentional exposure to or harmful effects of thrombolytic drug
  • Unintentional exposure to or harmful effects of anticoagulant antagonists, vitamin K or other coagulants
  • Unintentional exposure to or harmful effects of other fibrinolysis-affecting drugs
  • Unintentional exposure to or harmful effects of natural blood or blood products
  • Unintentional exposure to or harmful effects of acidifying or alkalising agents
  • Unintentional exposure to or harmful effects of other primarily systemic agents, not elsewhere classified
  • Unintentional exposure to or harmful effects of plasma substitutes
  • Unintentional exposure to or harmful effects of agents primarily affecting the cardiovascular system
  • Unintentional exposure to or harmful effects of cardiac-stimulant glycosides or drugs of similar action
  • Unintentional exposure to or harmful effects of calcium-channel blockers
  • Unintentional exposure to or harmful effects of other antidysrhythmic drugs
  • Unintentional exposure to or harmful effects of nitroglycerin, nitroglycerol, medicinal
  • Unintentional exposure to or harmful effects of other coronary vasodilators
  • Unintentional exposure to or harmful effects of angiotensin-converting-enzyme inhibitors
  • Unintentional exposure to or harmful effects of other antihypertensive drugs
  • Unintentional exposure to or harmful effects of antihyperlipidemic or antiarteriosclerotic drugs
  • Unintentional exposure to or harmful effects of peripheral vasodilators
  • Unintentional exposure to or harmful effects of antivaricose drugs, including sclerosing agents
  • Unintentional exposure to or harmful effects of agents primarily affecting the gastrointestinal system
  • Unintentional exposure to or harmful effects of histamine H2-receptor blockers
  • Unintentional exposure to or harmful effects of other antacids or anti-gastric-secretion drugs
  • Unintentional exposure to or harmful effects of stimulant laxatives
  • Unintentional exposure to or harmful effects of saline or osmotic laxatives
  • Unintentional exposure to or harmful effects of other laxatives
  • Unintentional exposure to or harmful effects of digestants
  • Unintentional exposure to or harmful effects of antidiarrhoeal drugs
  • Unintentional exposure to or harmful effects of emetics
  • Unintentional exposure to or harmful effects of agents primarily acting on smooth or skeletal muscles or the respiratory system
  • Unintentional exposure to or harmful effects of oxytocic drugs
  • Unintentional exposure to or harmful effects of skeletal muscle relaxants
  • Unintentional harmful effect of neuromuscular blocking agents
  • Unintentional exposure to or harmful effects of other drugs acting on muscles
  • Unintentional exposure to or harmful effects of unspecified drugs acting on muscles
  • Unintentional exposure to or harmful effects of antitussives
  • Unintentional exposure to or harmful effects of expectorants
  • Unintentional exposure to or harmful effects of other anti-common-cold drugs
  • Unintentional exposure to or harmful effects of salbutamol
  • Unintentional exposure to or harmful effects of aminophylline, theophylline
  • Unintentional exposure to or harmful effects of terbutaline
  • Unintentional exposure to or harmful effects of antiasthmatics, not elsewhere classified
  • Unintentional exposure to or harmful effects of topical agents primarily affecting skin or mucous membrane or ophthalmological, otorhinolaryngological or dental drugs
  • Unintentional exposure to or harmful effects of topical corticosteroid preparations
  • Unintentional exposure to or harmful effects of iodine, antiseptic
  • Unintentional exposure to or harmful effects of silver nitrate
  • Unintentional exposure to or harmful effects of other local antifungal, anti-infective or anti-inflammatory drugs
  • Unintentional exposure to or harmful effects of antipruritics
  • Unintentional exposure to or harmful effects of methyl salicylate
  • Unintentional exposure to or harmful effects of other local astringents or local detergents
  • Unintentional exposure to or harmful effects of emollients, demulcents or protectants
  • Unintentional exposure to or harmful effects of podophyllin
  • Unintentional exposure to or harmful effects of keratolytics, keratoplastics, or other hair treatment drugs or preparations
  • Unintentional exposure to or harmful effects of ophthalmological drugs or preparations
  • Unintentional exposure to or harmful effects of otorhinolaryngological drugs or preparations
  • Unintentional exposure to or harmful effects of fluoride preparations
  • Unintentional exposure to or harmful effects of other dental drugs, topically applied
  • Unintentional exposure to or harmful effects of camphor
  • Unintentional exposure to or harmful effects of agents primarily affecting water-balance or mineral or uric acid metabolism
  • Unintentional exposure to or harmful effects of mineralocorticoids
  • Unintentional exposure to or harmful effects of mineralocorticoids antagonists
  • Unintentional exposure to or harmful effects of loop diuretics
  • Unintentional harmful effect of high-ceiling diuretics
  • Unintentional exposure to or harmful effects of carbonic-anhydrase inhibitors
  • Unintentional exposure to or harmful effects of benzothiadiazine derivatives
  • Unintentional harmful effect of thiazides
  • Unintentional exposure to or harmful effects of other diuretics
  • Unintentional exposure to or harmful effects of electrolytic, caloric or water-balance agents
  • Unintentional exposure to or harmful effects of mineral salts, not elsewhere classified
  • Unintentional exposure to or harmful effects of drugs affecting uric acid metabolism
  • Unintentional exposure to or harmful effects of vitamin D or derivatives
  • Unintentional exposure to or harmful effects of bisphosphonates
  • Unintentional exposure to or harmful effects of appetite depressants
  • Unintentional exposure to or harmful effects of antidotes or chelating agents, not elsewhere classified
  • Unintentional exposure to or harmful effects of disulfiram
  • Unintentional exposure to or harmful effects of alcohol deterrents, not elsewhere classified
  • Unintentional exposure to or harmful effects of X-ray contrast media
  • Unintentional exposure to or harmful effects of MRI contrast agents
  • Unintentional exposure to or harmful effects of agents used for other scanning techniques
  • Unintentional exposure to or harmful effects of other diagnostic agents
  • Unintentional exposure to or harmful effects of lipotropic drugs
  • Unintentional exposure to or harmful effects of vitamins, not elsewhere classified, Pharmaceutical excipients
  • Unintentional exposure to or harmful effects of herbal preparations or formulas
  • Unintentional exposure to or harmful effects of dietary supplements, vitamins or minerals
  • Unintentional exposure to or harmful effects of complementary or traditional medicines, not elsewhere classified
  • Unintentional exposure to or harmful effects of complementary or traditional medicines, unspecified
  • Unintentional exposure to or harmful effects of vaccines immunoglobulins or other biological substances
  • Unintentional exposure to or harmful effects of BCG vaccine
  • Unintentional exposure to or harmful effects of typhoid or paratyphoid vaccine
  • Unintentional exposure to or harmful effects of cholera vaccine
  • Unintentional exposure to or harmful effects of plague vaccine
  • Unintentional exposure to or harmful effects of tetanus vaccine
  • Unintentional exposure to or harmful effects of diphtheria vaccine
  • Unintentional exposure to or harmful effects of Haemophilus influenzae type B vaccines
  • Unintentional exposure to or harmful effects of pertussis vaccine, including combinations with a pertussis component
  • Unintentional exposure to or harmful effects of mixed bacterial vaccines without a pertussis component
  • Unintentional exposure to or harmful effects of other or unspecified bacterial vaccines
  • Unintentional exposure to or harmful effects of smallpox vaccines
  • Unintentional exposure to or harmful effects of measles vaccines
  • Unintentional exposure to or harmful effects of mumps vaccines
  • Unintentional exposure to or harmful effects of rubella vaccines
  • Unintentional exposure to or harmful effects of polio vaccines
  • Unintentional exposure to or harmful effects of yellow fever vaccines
  • Unintentional exposure to or harmful effects of hepatitis A vaccines
  • Unintentional exposure to or harmful effects of hepatitis B vaccines
  • Unintentional exposure to or harmful effects of influenza vaccines
  • Unintentional exposure to or harmful effects of rotavirus vaccines
  • Unintentional exposure to or harmful effects of human papillomavirus vaccines
  • Unintentional exposure to or harmful effects of other viral vaccines
  • Unintentional exposure to or harmful effects of rickettsial vaccines
  • Unintentional exposure to or harmful effects of protozoal vaccines
  • Unintentional exposure to or harmful effects of hepatitis B immune globulin
  • Unintentional exposure to or harmful effects of antivenin, antivenom
  • Unintentional exposure to or harmful effects of immunoglobulin, not elsewhere classified
  • Unintentional exposure to or harmful effects of other specified vaccines
  • Unintentional exposure to or harmful effects of unspecified vaccines
  • Toxic effects of methamphetamine

Exclusions from above levels

  • http://id.who.int/icd/entity/1583926619 – Substances associated with injury or harm in therapeutic use

Sibling codes

  • PB20 – Unintentional exposure to or harmful effects of opioids or related analgesics
  • PB21 – Unintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants
  • PB22 – Unintentional exposure to or harmful effects of psychostimulants
  • PB23 – Unintentional exposure to or harmful effects of cannabinoids or hallucinogens
  • PB24 – Unintentional exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
  • PB25 – Unintentional exposure to or harmful effects of antidepressants
  • PB26 – Unintentional exposure to or harmful effects of antipsychotics
  • PB27 – Unintentional exposure to or harmful effects of antiepileptics or antiparkinsonism drugs
  • PB29 – Unintentional exposure to or harmful effects of multiple drugs, medicaments or biological substances

Foundation entity

Unintentional exposure to or harmful effects of other or unspecified drug, medicament or biological substance – http://id.who.int/icd/entity/799356470

Allowed postcoordination axes

Part of: 23: External causes of morbidity or mortality